Download PDF
Neuropediatrics 1982; 13(1): 24-33
DOI: 10.1055/s-2008-1059591
© Georg Thieme Verlag KG Stuttgart · New York

Phenobarbital Therapy in Neonatal Seizures and the Prognostic Value of the EEG1

F.  Staudt , Mary Louise Scholl , R. W. Coen , R. B. Bickford
  • Departments of Pediatrics, Neurology and Neurosciences, University of California at San Diego, La Jolla, California 92093, U.S.A.
1 Supported by a grant from the Deutsche Forschungsgemeinschaft (No. Sta 183/1).
Further Information

Publication History

Publication Date:
08 May 2008 (online)

  PDF Download  Permissions and Reprints

Abstract

High plasma levels of phenobarbital are known to produce profound effects on the EEG background activity. Phenobarbital therapy frequently is administered to the neonate with seizures prior to the first EEG recording. Therefore, it is questionable whether in these neonates alterations of the EEG background activity are related to anticonvulsive therapy.

A total of 26 neonates with seizures had an EEG while on phenobarbital therapy. In five cases an EEG was available prior to this treatment. Suppression of the background activity in the EEG was seen in 17 neonates of whom two had an inactive tracing and three a burst-suppression pattern. Moderate suppression occurred in five infants, mild suppression in seven infants. The suppression of the background activity correlated with the clinical outcome. The phenobarbital plasma levels in the group with severe or moderate suppression, mild suppression and normal background activity did not show statistically significant differences. Thus, the suppression of the EEG background activity in neonates with phenobarbital plasma levels of l .3 to 5.9 mg/dl are secondary to brain pathology rather than medication.

Key words

Neonatal seizures - Neonatal EEG - Phenobarbital

      >